Clofazimine as a Treatment for Multidrug-Resistant Tuberculosis: A Review

Clofazimine as a Treatment for Multidrug-Resistant Tuberculosis: A Review

Multidrug-resistant tuberculosis (MDR-TB) is an infectious disease caused by <i>Mycobacterium tuberculosis</i> which is resistant to at least isoniazid and rifampicin. This disease is a worldwide threat and complicates the control of tuberculosis (TB). Long treatment duration, a combinat...

Full description

Bibliographic Details
Main Authors: Rhea Veda Nugraha, Vycke Yunivita, Prayudi Santoso, Rob E. Aarnoutse, Rovina Ruslami
Format: Article
Language:English
Published: Österreichische Apotheker-Verlagsgesellschaft m. b. H. 2021-05-01
Series:Scientia Pharmaceutica
Subjects:
clofazimine
MDR-TB
efficacy
safety
tolerability
Online Access:https://www.mdpi.com/2218-0532/89/2/19

Internet

https://www.mdpi.com/2218-0532/89/2/19

Similar Items